![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
南美洲白细胞去除术市场预测至 2028 年 - COVID-19 影响和按产品类型(白细胞去除术设备和白细胞去除术一次性用品)、应用(研究应用和治疗应用)和最终用户(血液成分提供商和血液中心、学术和研究机构)进行的区域分析、制药和生物技术公司以及医院和输血中心)
市场介绍
南美白细胞去除术市场基于三个大国进行分析:巴西、阿根廷和 SAM 的其他国家。巴西在白细胞分离术市场的增长中贡献了主要份额。在巴西,镰状细胞病是最常见的遗传性疾病之一。据了解,巴西每年有 700 至 1000 名出生时患有 SCD 的儿童。该疾病最常见的类型是镰状细胞性贫血 (SCA),它是由 β-珠蛋白基因的单一突变引起的。在巴西,镰状细胞性贫血的发生率各不相同,在马拉尼奥等贫困指数较高且非洲裔人数较多的州,镰状细胞性贫血的发病率明显较高。近年来,该国儿童白血病病例也有所增加。巴西的白血病病例随着时间的推移而增加,目前是该国第九大常见癌症。发现其在男性中的患病率相当高,每百万居民中有 41.7 至 57.5 例病例。此外,该国各地区白血病病例的比例差异很大,并且自国家癌症研究所 (INCA) 发布上次报告以来有所上升。巴西北部地区的白血病病例数位居第二。它还拥有最低的城市人类发展指数(mHDI),因此导致了最高的儿童死亡率。因此,由于镰状细胞性贫血和白血病病例的增加,预计该国将在预测期内为市场提供增长机会。
南美洲的 COVID-19 数量不断增加疫情爆发以来的病例数。巴西、阿根廷和哥伦比亚的病例正在增加。 COVID-19预计将导致该地区最严重的经济衰退,导致2020年地区GDP萎缩9.1%。这预计将使贫困人口增加4500万,极端贫困人口增加2800万。新冠病毒? 19日大流行对南美洲已经负担过重且资金不足的公共医疗系统来说是一次严峻的考验。它遭受着严重的不平等。国营医院和诊所因媒介传播疾病和社区获得性感染的治疗以及非传染性疾病 (NCD) 的高发病率而承受过重压力。此外,南美洲的国内生产总值(GDP)和中央政府医疗保健支出均显着低于发达国家。根据联合国拉丁美洲经济委员会 (CEPAL) 的数据,2018 年,16 个南美国家用于医疗保健的投资不到 GDP 的 4%。公共医疗保健系统缺乏投资的后果在疫情期间得到了体现。 COVID-19 大流行威胁着国有医疗保健系统的基础设施和能力,从而加剧了这些不平等。因此,上述因素对该地区市场的增长产生了负面影响。
市场概况和动态
南美洲的白细胞分离术市场预计将从2021年的492万美元增长到2028年的789万美元;预计 2021 年至 2028 年复合年增长率为 7.0%。血液疾病扰乱患者的整体健康。贫血;血友病;冯·维勒布兰德病(VWD);骨髓瘤、白血病和淋巴瘤等血液癌症是常见的血液疾病。新诊断的白血病病例数从 1990 年的 354,500 例增加到 2017 年的 518,500 例。根据美国疾病控制与预防中心 (CDC) 的数据,大约每 5,000 名男新生儿中就有 1 人患有 A 型血友病。 CDC 2017 年调查报告称,冯·维勒布兰德病 (VWD) 是最常见的出血性疾病之一,影响高达 1% 的人口。 2012 年至 2016 年期间,有超过 14,600 名男性、女性和儿童在血友病治疗中心接受 VWD 治疗。这些疾病发病率的上升使得输血的需求最大化,从而增加了对白细胞分离设备的需求。用于去除血液中有害物质的两种最常见的单采术类型是细胞单采术和血浆置换。血浆置换用于治疗重症肌无力、血栓性血小板减少性紫癜和多发性硬化症等疾病。细胞去除术是一种去除多余血细胞的过程,用于治疗白血病、红细胞增多症和血小板增多症等。
主要细分市场
从产品类型来看,2021年白细胞分离一次性用品细分市场占有较大份额。从应用来看,2021年研究应用细分市场占有最大份额。基于最终用户,血液成分提供商和血液中心细分市场在 2021 年占据最大份额。
主要来源和上市公司
<准备本南美白细胞分离术市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有:旭化成株式会社;费森尤斯公司两合公司;血液公司;泰尔茂公司; STEMCELL 技术公司;赫马护理;玛科制药公司;所有细胞;和 BioIVT 等。购买报告的理由
- 了解南美白细胞分离术市场格局,并确定最有可能保证强劲回报的细分市场
- 通过了解不断变化的市场形势,保持领先地位南美洲白细胞分离术市场的竞争格局
- 通过确定最有可能销售的细分市场,有效规划南美白细胞分离术市场的并购和合作伙伴交易
- 帮助做出明智的业务决策通过对南美白细胞分离术市场各个细分市场表现的敏锐和全面的分析
- 获得南美地区2021-2028年各个细分市场的市场收入预测。 li>
南美洲白细胞分离术市场细分
南美洲白细胞去除术市场 –按产品类型
- 白细胞去除一次性用品
- 白细胞去除设备
South美国白细胞分离术市场 –按应用
- 研究应用
- 治疗应用
南美洲白细胞去除术市场 –按最终用户划分
- 血液成分提供商和血液中心
- 医院和输血中心
- 制药和生物技术公司
- 学术和研究机构
南美洲白细胞去除术市场 -按国家/地区
- 巴西
- 阿根廷
- 南美洲其他地区
南美洲白细胞去除术市场 –提及的公司
- 旭化成株式会社
- Fresenius SE & ;
- Haemonetics Corporation
- 泰尔茂株式会社 ;
- STEMCELL Technologies Inc.   ;
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South America Leukapheresis Market – By Product Type
1.3.2 South America Leukapheresis Market – By Application
1.3.3 South America Leukapheresis Market – By End User
1.3.4 South America Leukapheresis Market – By Country
2. South America Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South America Leukapheresis – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. South America Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Fostering Number of Voluntary Blood Donors
5.1.2 Elevating Incidence of Hematologic Diseases
5.1.3 Raising Elderly Population
5.2 Key Market Restraints
5.2.1 Excessive Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Amplifying Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Growth in Therapeutic Apheresis
5.5 Impact Analysis
6. South America Leukapheresis – Market Analysis
6.1 South America Leukapheresis Market Revenue Forecast and Analysis
7. South America Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 South America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. South America Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 South America Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. South America Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 South America Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. South America Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 South America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Brazil: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.1.2.1 Brazil: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.3 Brazil: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.4 Brazil: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 Argentina: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.2.2.1 Argentina: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.3 Argentina: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.4 Argentina: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 Rest of South America: Leukapheresis Market, By Product Type, 2019–2028 (USD Million)
10.1.1.3.2.1 Rest of South America: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.3 Rest of South America: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.4 Rest of South America: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. South America Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BioIVT
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South America: Leukapheresis Market, By Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South America Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South America Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South America Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. South America Leukapheresis Market Segmentation
Figure 2. South America Leukapheresis Market Segmentation, By country
Figure 3. Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South America Leukapheresis Market, Industry Landscape
Figure 7. South America PEST Analysis
Figure 8. South America Leukapheresis market impact analysis of driver and restraints
Figure 9. South America Leukapheresis Market – Revenue Forecast and Analysis to 2020-2028
Figure 10. South America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. South America Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. South America Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. South America: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. South America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. Brazil: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Argentina: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of South America: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact Of COVID-19 Pandemic In South America Market
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution